DSHEA Third-Party Literature Constraints Violate First Amendment – Lawsuit
This article was originally published in The Tan Sheet
The restrictions on third-party literature mandated by the Dietary Supplement Health & Education Act are a violation of the First Amendment's protection of free speech, supplement marketer American Longevity argues in a recent lawsuit against FDA filed in Southern California federal court
You may also be interested in...
FDA is seeking a permanent injunction against the sale of Lane Labs-USA's BeneFin, SkinAnswer and MGN-3 products, alleging they are "unapproved drugs" and "illegally promoted as treatments for cancer and other diseases."
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning